Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 3.500
-0.080 (-2.23%)
At close: Feb 24, 2026
Carvolix Market Cap
Carvolix has a market cap or net worth of €140.87 million as of February 24, 2026. Its market cap has increased by 157.56% in one year.
Market Cap
140.87M
Enterprise Value
158.94M
Revenue
5.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.50
Market Cap Chart
Since June 14, 2021, Carvolix's market cap has decreased from 145.31M to 140.87M, a decrease of -3.06%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 137.72M | 102.31% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | 145.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 236.10M |
| Median Technologies | 177.21M |
| Guerbet | 167.60M |
| Diagnostic Medical Systems | 34.32M |
| Theraclion | 29.60M |
| Novacyt | 27.50M |
| Implanet | 25.62M |
| Ikonisys | 25.43M |